6E11, a highly selective inhibitor of Receptor-Interacting Protein Kinase 1, protects cells against cold hypoxia-reoxygenation injury
Authors:
Open Access
- 10 October 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-13
Abstract
Necroptosis is a programmed cell death pathway that has been shown to be of central pathophysiological relevance in multiple disorders (hepatitis, brain and cardiac ischemia, pancreatitis, viral infection and inflammatory diseases). Necroptosis is driven by two serine threonine kinases, RIPK1 (Receptor Interacting Protein Kinase 1) and RIPK3, and a pseudo-kinase MLKL (Mixed Lineage Kinase domain-Like) associated in a multi-protein complex called necrosome. In order to find new inhibitors for use in human therapy, a chemical library containing highly diverse chemical structures was screened using a cell-based assay. The compound 6E11, a natural product derivative, was characterized as a positive hit. Interestingly, this flavanone compound: inhibits necroptosis induced by death receptors ligands TNF-α (Tumor Necrosis Factor) or TRAIL (TNF-Related Apoptosis-Inducing Ligand); is an extremely selective inhibitor, among kinases, of human RIPK1 enzymatic activity with a nM Kd; has a non-ATP competitive mode of action and a novel putative binding site; is weakly cytotoxic towards human primary blood leukocytes or retinal pigment epithelial cells at effective concentrations; protects human aortic endothelial cells (HAEC) from cold hypoxia/reoxygenation injury more effectively than necrostatin-1 (Nec-1) and Nec-1s. Altogether, these data demonstrate that 6E11 is a novel potent small molecular inhibitor of RIPK1-driven necroptosis.Keywords
This publication has 24 references indexed in Scilit:
- Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasisNature, 2016
- An outline of necrosome triggersCellular and Molecular Life Sciences, 2016
- Regulated necrosis: disease relevance and therapeutic opportunitiesNature Reviews Drug Discovery, 2016
- Necroptosis, in vivo detection in experimental disease modelsSeminars in Cell & Developmental Biology, 2014
- Regulated necrosis: the expanding network of non-apoptotic cell death pathwaysNature Reviews Molecular Cell Biology, 2014
- Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with NecroptosisACS Medicinal Chemistry Letters, 2013
- Methods to Analyze Cellular Necroptosis2009
- Identification of RIP1 kinase as a specific cellular target of necrostatinsNature Chemical Biology, 2008
- Structure–activity relationship study of novel necroptosis inhibitorsBioorganic & Medicinal Chemistry Letters, 2005
- Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injuryNature Chemical Biology, 2005